Ledger.Open graph →
SEC Form D · filed August 14, 2014

PROTEOSTASIS THERAPEUTICS, INC

Offering
$10.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Peter Pau · Menlo Park, CADirectorThomas Arnold · Wilmington, DEDirectorJohn L. Atkins, Iii · Pasadena, CAExecThomas J. Andrews · Pasadena, CADirectorPeter M. Moglia · Pasadena, CAExec · DirectorJames H. Richardson · Pasadena, CAExec · DirectorDean A. Shigenaga · Pasadena, CADirectorJoel S. Marcus · Pasadena, CAExecDaniel J. Ryan · Pasadena, CAExec · DirectorRichard B. Jennings · Pasadena, CAExec · DirectorStephen A. Richardson · Pasadena, CAExec · DirectorRichard H. Klein · Pasadena, CAExecMaria C. Freire, Ph.D · Pasadena, CAExecSteven R. Hash · Pasadena, CADirectorJeffrey Goldberg · NEW YORK, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗